Overview of Measure 106
Measure 106 on the Oregon ballot addresses physician-assisted dying for eligible terminally ill adults. If passed, it would amend state law to create a structured process for requesting and administering life-ending medication, while adding new oversight and requirements. This overview explains the background, key provisions, and potential impacts in straightforward terms.
Background on Assisted Dying in Oregon
Oregon was the first U.S. state to legalize physician-assisted dying through the Death with Dignity Act, passed by voters in 1994 and implemented in 1997. The law sets strict eligibility criteria, including terminal illness with a prognosis of six months or less to live, voluntary and informed requests, and capacity to make healthcare decisions. Since implementation, annual reports have tracked participation, safeguards, and demographic trends.
What Measure 106 Would Change
Expanding Eligibility to Terminal Conditions Requiring Palliative Sedation
Measure 106 would allow a qualified terminally ill patient who is experiencing unbearable suffering from conditions that necessitate palliative sedation to request life-ending medication. Under current law, only patients with a prognosis of six months or less may request medication; this change would extend access to patients whose primary need is sedation to relieve intractable symptoms, even if their life expectancy extends beyond six months.
Requirements and Safeguards
The initiative maintains existing safeguards while adding new procedural steps. A second attending physician must confirm eligibility, and a consulting physician must be consulted when palliative sedation is the context. The process for requesting medication, including written and oral requests, waiting periods, and witness requirements, remains largely aligned with current statute. Mental health assessments and capacity evaluations are emphasized to ensure patient decision-making is voluntary and informed.
Key Provisions at a Glance
| Provision> | Current Law | Measure 106 Proposal | Purpose |
|---|---|---|---|
| Eligibility BasisTerminal illness prognosis (≤6 months)Terminal illness + need for palliative sedation | Define the medical basis for access | ||
| Second Physician ConfirmationRequiredRequired | Confirm eligibility and capacity | ||
| Consulting Physician in Sedation CasesNot requiredRequired when sedation is primary reason | Ensure appropriate expertise | ||
| Mental Health AssessmentRequired if capacity questionedRequired if capacity questioned | Protect decision-making capacity | ||
| Reporting and OversightAnnual reports to Oregon Health AuthorityContinues with new data elements | Monitor implementation and trends |
Potential Impacts and Considerations
By including patients who require palliative sedation, Measure 106 could expand access to medically assisted dying for individuals with longer prognoses but severe, unmanageable symptoms. Supporters argue this better reflects patient experiences and alleviates suffering that is refractory to standard care. Critics raise questions about the adequacy of palliative alternatives, the risk of coercion, and the ethics of extending assisted dying to cases driven primarily by symptom control rather than a terminal timeline. Implementation would depend on regulatory clarity, provider training, and ongoing monitoring of outcomes and safeguards.
Frequently Asked Questions
- Who would be eligible under Measure 106?Terminally ill adults with a qualified diagnosis, capable of making informed decisions, and, under the proposal, those whose primary need is palliative sedation regardless of a six-month prognosis.
- What safeguards remain in place?Requirements for two attending physicians, capacity assessments, voluntary and informed requests, waiting periods, and detailed reporting continue; additional consultation is required when sedation is the principal rationale.
- Does this change how palliative care is provided?It adds a new pathway for patients whose suffering is linked to conditions requiring sedation, without altering existing palliative care options or obligations.
- Will records be public?Statistical summaries are published annually; individual patient information remains confidential per law.
- How is Oregon monitoring outcomes already?Annual reports track demographics, medical conditions, timelines, and compliance metrics to evaluate safety and trends.
Context and Related Policies
Oregon’s Death with Dignity Act operates within a broader landscape of end-of-life care policies, including advance care planning, hospice, and palliative care. Measure 106 interacts with these systems by offering an additional option for symptom management when sedation is necessary. Other states with similar laws have different eligibility criteria and reporting practices; Oregon’s experience provides one data point within a diverse policy environment.
Terms to Know
- Physician-assisted dying:A licensed physician provides a patient with the means to end their own life, typically via prescribed medication, at the patient’s voluntary request.
- Palliative sedation:The use of medication to relieve severe symptoms when suffering is refractory to other treatments, often near end of life.
- Terminal illness:A condition expected to lead to death, with prognosis and trajectory varying by disease and patient.
- Capacity:The cognitive ability to understand and make a decision rationally and voluntarily.
Next Steps for Voters
To understand how Measure 106 would apply, voters should review the official text, supporting analyses, and summaries prepared by nonpartisan legislative services. Talking with healthcare providers, ethicists, and patient advocates can clarify practical implications. Individual decisions about end-of-life care remain personal; the measure, if enacted, would adjust the legal framework within which those decisions are made.
Conclusion
Measure 106 Oregon proposes to refine the state’s assisted dying statute by including situations where palliative sedation is medically necessary. It preserves existing eligibility processes and reporting while introducing a pathway for patients whose primary need is symptom control. Understanding the specifics of the proposal, alongside ongoing oversight and public reporting, helps contextualize its potential effects on patients, providers, and the broader system of end-of-life care.